Kenneth Mario Ward, APRN

Kenneth Ward practices at The University of Texas MD Anderson Cancer Center in Houston, Texas, part of The University of Texas System.

Kenneth Ward's NPI, 1386012086, was assigned on September 11, 2015. Kenneth Ward holds Texas license AP127988.

Kenneth Ward's primary practice is The University of Texas MD Anderson Cancer Center, at 1515 Holcombe Blvd, Houston, TX 77030.

Kenneth Ward's primary practice is The University of Texas MD Anderson Cancer Center in Houston, Texas, part of The University of Texas System. The medical group on file is Physicians Referral Service.

Dmand AI tracks the electronic health record (EHR) system at each site where Kenneth Ward practices. Vendor and product names are available with a free account.

Gerontology is Kenneth Ward's primary specialty in the NPI Registry, under taxonomy code 363LG0600X. Kenneth Ward is licensed in Texas.

CMS counts 74 Medicare patients who saw Kenneth Ward in 2024. The largest group is 65 to 74, with 33 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. Their average risk score is 3.22, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Kenneth Ward's median patient age at 72, with 51% women.

In 2024, Kenneth Ward wrote 50 Medicare Part D claims for 25 patients. 76% of them were for generic drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Kenneth Ward for performance year 2024, reported as part of a group. Kenneth Ward accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Kenneth Ward as offering telehealth.

CMS Open Payments shows 1 general payment to Kenneth Ward from 1 drug or device company in 2025. Food and beverage make up the largest share, 100% of the total. Otsuka America Pharmaceutical, Inc. paid the most, $29.